Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Core Laboratories NV Lowers Q3 2012 Guidance; Comments On Q4 2012 Guidance


Monday, 1 Oct 2012 04:37pm EDT 

Core Laboratories NV announced that for the third quarter of 2012, it expects consolidated revenues will be within the $240 million to $245 million range with EPS in the range of $1.09 to $1.13 per share. For the fourth quarter of 2012, it expects revenues and earnings to be similar to the third quarter of 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $256 million and EPS of $1.22 for the third quarter of 2012; revenue of $267 million and EPS of $1.29 for the fourth quarter of 2012. 

Company Quote

193.99
-19.7 -9.22%
4:00pm EDT